Glatt can optimize the active substance release and bioavailability by specific optimized formulation and process methods depending on the physico-chemical property of the active substance.
The Glatt MicroPX™ technology (micro pelletizing technology) is a continuous fluidized bed agglomeration procedure for the manufacture of pellets and micropellets with a very high active ingredient content.
Glatt has many years of experience and expertise in the taste masking of APIs. With our technologies and formulation approaches, we are able to achieve effective taste masking of drugs. A proven approach is the micro-pelletizing of APIs with the subsequen
The formulation development center at Ascent offers physical characterization of powders which includes particle size distribution, bulk and tap density determination, flow properties etc.
With expertise in characterizing and modifying a drug substanceâ€™s physical, chemical and mechanical properties, our objective is to help you assess and choose the best solid form for progression into animal and human dosing trials.
Ascents offerings includes binary or ternary mixtures of API with excipients from various functional categories such as diluents, binders, glidants, disintegrants, lubricants etc., packaging material compatibility studies, selection of excipients for form
AMRI's PAT approach is consistent with the FDA perspective that quality cannot be tested into products, but should be built in.
Sub Category See All
API Screening (2)
Excipient Screening (13)
Salt Screening (6)
Taste Masking (5)
Country See All
New Zealand (1)
United Kingdom (3)
United States (7)
Companies See All